Glioma
This group comprises anaplastic astrocytomas and glioblastoma multiforme. Whereas the median overall survival of anaplastic (WHO grade III) gliomas is approximately 3 years, glioblastoma multiforme has a poor median overall survival of c. 15 months.
Melanoma
Stage I / II: Invasive melanoma, 89–95% survival
Stage II: High risk melanoma, 45–79% survival